• Font Size
Boston Biomedical information
Boston Biomedical: Innovation for life. Conquering cancer through cutting-edge therapeutics
Boston Biomedical: Targeting the Root of Cancer. Developing novel therapeutics through research into cancer stem cells
Boston Biomedical: At the forefront of medical innovation. Award-winning R and D technology and a leading pipeline of therapeutics targeting cancer stem cells

About Us

Boston Biomedical is focused on the research and development of novel cancer therapeutics, and has developed a world-leading product pipeline targeting cancer stem cells.

Product Pipeline

BBI608 is the most clinically advanced candidate in Boston Biomedical’s cancer stem cell (CSC) pathway inhibitor program. This first-in-class, orally-administered small molecule blocks CSC self-renewal and induces cell death in CSCs as well as non-stem cancer cells.

Tell me more